D. J. Meiklejohn

619 total citations
15 papers, 437 citations indexed

About

D. J. Meiklejohn is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, D. J. Meiklejohn has authored 15 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in D. J. Meiklejohn's work include Lymphoma Diagnosis and Treatment (5 papers), Platelet Disorders and Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). D. J. Meiklejohn is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Platelet Disorders and Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). D. J. Meiklejohn collaborates with scholars based in United Kingdom, United States and Australia. D. J. Meiklejohn's co-authors include M. Greaves, Mark A. Vickers, Henry G. Watson, Mary Joan MacLeod, S. J. Urbaniak, John Davies, Kathleen Beusterien, M.J. Leach, Helen Lemmon and Gerome Breen and has published in prestigious journals such as Neurology, Stroke and British Journal of Haematology.

In The Last Decade

D. J. Meiklejohn

15 papers receiving 422 citations

Peers

Countries citing papers authored by D. J. Meiklejohn

Since Specialization

Citations

This map shows the geographic impact of D. J. Meiklejohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. J. Meiklejohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. J. Meiklejohn more than expected).

Fields of papers citing papers by D. J. Meiklejohn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. J. Meiklejohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. J. Meiklejohn. The network helps show where D. J. Meiklejohn may publish in the future.

Co-authorship network of co-authors of D. J. Meiklejohn

This figure shows the co-authorship network connecting the top 25 collaborators of D. J. Meiklejohn. A scholar is included among the top collaborators of D. J. Meiklejohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. J. Meiklejohn. D. J. Meiklejohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Utility of minimal preparation computed tomography colonography in detecting colorectal cancer in elderly and frail patients 2018 ·Internal Medicine Journal ·D. J. Meiklejohn, Lloyd J Ridley, Meng Ngu, (unknown), (unknown), William E Ridley	4
2	Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal 2018 ·PharmacoEconomics ·Paul Tappenden, Emma Simpson, Jean Hamilton, Daniel Pollard, Mark Clowes, Eva Kaltenthaler, D. J. Meiklejohn, Nicholas Morley	2
3	Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study 2010 ·Health and Quality of Life Outcomes ·Kathleen Beusterien, John Davies, M.J. Leach, D. J. Meiklejohn, (unknown), (unknown), (unknown)	93
4	Multifocal primary extranodal B-cell non-Hodgkin’s lymphoma involving six extranodal sites: Figure 1 2008 ·Journal of Clinical Pathology ·Jeffrey W. Craig, K.J. Walker, (unknown), (unknown), (unknown), D. J. Meiklejohn, Neil Kernohan, Sudhir Tauro	1
5	C-MYCtranslocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator? 2008 ·Leukemia & lymphoma ·Lesley Christie, Neil Kernohan, (unknown), Mark Sales, Joan Cunningham, (unknown), Paul Batstone, D. J. Meiklejohn, John R. Goodlad	41
6	The relationships of ABO, Lewis and Secretor blood groups with cerebral ischaemia of arterial origin 2005 ·Journal of Thrombosis and Haemostasis ·Peter Clark, D. J. Meiklejohn, (unknown), Mark A. Vickers, M. Greaves	14
7	Application of combined immunofluorescence and fluorescence in situ hybridization on paraffin‐embedded sections to characterize T‐cell lymphoma with EBV‐infected B‐cell blasts 2004 ·Genes Chromosomes and Cancer ·Genevieve K. Temple, (unknown), Neil Kernohan, Fiona Scott, D. J. Meiklejohn, Norman Pratt	6
8	Lack of association between apolipoprotein E genoype and ischaemic stroke in a Scottish population 2001 ·European Journal of Clinical Investigation ·Mary Joan MacLeod, (unknown), Gerome Breen, D. J. Meiklejohn, Helen Lemmon, David St Clair	50
9	Combined risk factors contributing to cerebral venous thrombosis in a young woman 2001 ·The Journal of Laryngology & Otology ·Bhaskar Ram, D. J. Meiklejohn, Desmond A. Nunez, Alison D. Murray, Henry G. Watson	6
10	In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib 2001 ·British Journal of Haematology ·D. J. Meiklejohn, Mark A. Vickers, (unknown), (unknown), Iain Moore, S. J. Urbaniak, M. Greaves	34
11	Acquired haemophilia in association with organ‐specific autoimmune disease 2001 ·Haemophilia ·D. J. Meiklejohn, Henry G. Watson	36
12	Plasma Homocysteine Concentrations in the Acute and Convalescent Periods of Atherothrombotic Stroke 2001 ·Stroke ·D. J. Meiklejohn, Mark A. Vickers, (unknown), M. Greaves	71
13	Platelet glycoprotein IIIa polymorphism HPA 1b (Pl^A2): no association with platelet fibrinogen binding 1999 ·British Journal of Haematology ·D. J. Meiklejohn, S. J. Urbaniak, M. Greaves	32
14	No association between Glu/Asp polymorphism of NOS3 gene and ischemic stroke 1999 ·Neurology ·Mary Joan MacLeod, (unknown), Alistair Cumming, D. J. Meiklejohn, Duncan Shaw, David St Clair	43
15	Sea-blue histiocytosis and pancytopaenia associated with chronic total parenteral nutrition administration 1997 ·Clinical & Laboratory Haematology ·D. J. Meiklejohn, H Baden, M. Greaves	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact